• Date: Wednesday 18 August
• Time: 12:30pm - 1:30pm
• Venue: Virtual Auditorium 

Sarah Alexandrou

Sarah is a Phd student in the Replication and Genome Stability Lab at Garvan. She is studying how cellular abnormalities could contribute to the development of therapeutic resistant in breast cancer. Sarah's work has won many awards at Garvan and she is passionate about the need to identify and develop novel therapeutic strategies to improve patient outcomes. 

Susan Clark

Professor Susan Clark FAA is Leader of the Genomics and Epigenetics Research Theme and Head of the Epigenetics Research Lab at Garvan.

Professor Clark is a worldwide pioneer of epigenetics - the study of the additional layer of instructions on DNA that organises and regulates gene activity. Her search has helped revolutionise the field through new technologies that profile DNA changes in early development and cancer, and has laid the groundwork for using epigenetics to detect and monitor cancer progression. 

Elissa Deenick 

Associate Professor Elissa Deenick is Head of the Lymphocyte Signalling and Activation Laboratory at Garvan. Her research is focused on lymphocyte activation and differentiation, and how this is controlled to ensure protection against infection while avoiding harmful immune responses like allergy and autoimmunity.